Literature DB >> 16703458

Evaluating the effect of sulphated polysaccharides on cyclosporine a induced oxidative renal injury.

Anthony Josephine1, Coothan Kandaswamy Veena, Ganapathy Amudha, Sreenivasan P Preetha, Palaninathan Varalakshmi.   

Abstract

Cyclosporine A (CsA) has been universally used as an immunosuppressant for the management of organ transplantation and various autoimmune diseases. However, nephrotoxicity due to CsA remains to be an important clinical challenge. In the present investigation, an attempt has been made to appraise the effect of sulphated polysaccharides on oxidative renal injury caused by CsA. Adult male Wistar rats were divided into four groups. Two groups received CsA by oral gavage (25 mg/kg body weight) for 21 days to provoke nephrotoxicity, one of which simultaneously received sulphated polysaccharides subcutaneously, (5 mg/kg body weight). A vehicle (olive oil) treated control group and sulphated polysaccharides drug control were also built-in. An increase in lipid peroxidation along with abnormal levels of enzymic (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase and glucose-6-phosphate dehydrogenase) and non-enzymic antioxidants (glutathione, vitamin C and vitamin E) are the salient features observed in CsA induced nephrotoxicity. CsA induced impairment of renal toxicity was evident from the marked decline in the activities of renal marker enzymes like alkaline phosphatase, acid phosphatase and lactate dehydrogenase, as well as an apparent increase in the serum urea, uric acid and creatinine; diagnostic of renal damage was normalized by sulphated polysaccharides co-administration. Sulphated polysaccharides treatment showed an effectual role in counteracting the free radical toxicity by bringing about a significant decrease in peroxidative levels and increase in antioxidant status. These observations emphasize the antioxidant property of sulphated polysaccharides and its cytoprotective action against CsA induced nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16703458     DOI: 10.1007/s11010-005-9081-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  40 in total

Review 1.  Mechanisms of nephrotoxicity.

Authors:  J M Campistol; S H Sacks
Journal:  Transplantation       Date:  2000-06-27       Impact factor: 4.939

2.  A rapid method for the estimation of urea in biologic fluids.

Authors:  S NATELSON; M L SCOTT; C BEFFA
Journal:  Am J Clin Pathol       Date:  1951-03       Impact factor: 2.493

3.  Purification and properties of glutathione reductase of human erythrocytes.

Authors:  G E Staal; J Visser; C Veeger
Journal:  Biochim Biophys Acta       Date:  1969-07-08

Review 4.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

5.  Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine. Protective effects of vitamins E and C.

Authors:  I Durak; H I Karabacak; S Büyükkoçak; M Y Cimen; M Kaçmaz; E Omeroglu; H S Oztürk
Journal:  Nephron       Date:  1998       Impact factor: 2.847

6.  Selenium: biochemical role as a component of glutathione peroxidase.

Authors:  J T Rotruck; A L Pope; H E Ganther; A B Swanson; D G Hafeman; W G Hoekstra
Journal:  Science       Date:  1973-02-09       Impact factor: 47.728

7.  Effect of cyclosporine A on accumulation of tetraethylammonium and p-aminohippurate, and on lipid peroxidation in rat renal microsomes and cortical slices.

Authors:  G Inselmann; K Baumann
Journal:  Ren Fail       Date:  1990       Impact factor: 2.606

Review 8.  Tissue glutathione, nutrition, and oxidative stress.

Authors:  T M Bray; C G Taylor
Journal:  Can J Physiol Pharmacol       Date:  1993-09       Impact factor: 2.273

9.  Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals.

Authors:  E Pigeolet; P Corbisier; A Houbion; D Lambert; C Michiels; M Raes; M D Zachary; J Remacle
Journal:  Mech Ageing Dev       Date:  1990-02-15       Impact factor: 5.432

10.  Synergistic toxicity of cyclosporin A and streptomycin in renal epithelial cell cultures.

Authors:  R J Walker; V A Lazzaro; G G Duggin; J S Horvath; D J Tiller
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1988-12
View more
  5 in total

1.  ILB®, a Low Molecular Weight Dextran Sulphate, Restores Glutamate Homeostasis, Amino Acid Metabolism and Neurocognitive Functions in a Rat Model of Severe Traumatic Brain Injury.

Authors:  Giacomo Lazzarino; Valentina Di Pietro; Marco Rinaudo; Zsuzsanna Nagy; Nicholas M Barnes; Lars Bruce; Stefano Signoretti; Renata Mangione; Miriam Wissam Saab; Barbara Tavazzi; Antonio Belli; Giuseppe Lazzarino; Angela Maria Amorini; Ann Logan
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

2.  Role of sulphated polysaccharides from Sargassum Wightii in Cyclosporine A-induced oxidative liver injury in rats.

Authors:  Anthony Josephine; Kalaiselvam Nithya; Ganapathy Amudha; Coothan Kandaswamy Veena; Sreenivasan P Preetha; Palaninathan Varalakshmi
Journal:  BMC Pharmacol       Date:  2008-02-20

Review 3.  Use of antioxidants to prevent cyclosporine a toxicity.

Authors:  Jinhwa Lee
Journal:  Toxicol Res       Date:  2010-09

4.  Repair of Tea Polysaccharide Promotes the Endocytosis of Nanocalcium Oxalate Monohydrate by Damaged HK-2 Cells.

Authors:  Chuang-Ye Li; Li Liu; Yao-Wang Zhao; Qian-Long Peng; Xin-Yuan Sun; Da Guo; Jian-Ming Ouyang
Journal:  Oxid Med Cell Longev       Date:  2020-04-25       Impact factor: 6.543

5.  Low Molecular Weight Dextran Sulfate (ILB®) Administration Restores Brain Energy Metabolism Following Severe Traumatic Brain Injury in the Rat.

Authors:  Giacomo Lazzarino; Angela Maria Amorini; Nicholas M Barnes; Lars Bruce; Alvaro Mordente; Giuseppe Lazzarino; Valentina Di Pietro; Barbara Tavazzi; Antonio Belli; Ann Logan
Journal:  Antioxidants (Basel)       Date:  2020-09-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.